BioXcel Therapeutics sells strategic assets to OnkoSxcel
BioXcel Therapeutics entered into an asset purchase agreement with OnkoSxcel Therapeutics to sell its oncology business, signaling a strategic shift towards non-oncology focus. The agreement is dated August 27, 2026, with closing conditions to be satisfied.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed